Related by context. All words. (Click for frequent words.) 73 targeted radiotherapeutic 72 oral prodrug 72 Angiocept 72 candidate deforolimus 71 novel therapeutic antibodies 70 Aflibercept 70 virus HCV protease inhibitor 70 AAG geldanamycin analog 70 Personalized Immunotherapy 70 2 methoxyestradiol 70 OncoVex 70 GVAX ® 69 ALN PCS 69 Onconase 69 product candidate Lpathomab 69 Xcytrin R 69 IMA# 69 IMPDH inhibitor 69 HSP# inhibitor 69 PNT# 69 molecular imaging radiopharmaceutical 69 thalidomide Thalomid 69 non nucleoside inhibitor 69 imatinib Gleevec ® 69 MKC# MT 69 Initiates Phase II 69 Sphingomab 69 Alfacell proprietary ribonuclease 69 orally administered inhibitor 69 PF # [002] 68 ASONEP ™ 68 LymphoStat B TM 68 ASONEP TM 68 gastro intestinal inflammation 68 Spiegelmer ® 68 therapeutic monoclonal antibody 68 LymphoStat B belimumab 68 triggers apoptosis programmed 68 dasatinib Sprycel ® 68 VitiGam 68 SinuNase ™ 68 novel immunotherapies 68 Prodarsan R 68 targeted antifolate 68 Panzem R 68 Squalamine 68 INS# [001] 68 proteasome inhibitor 68 NPC 1C 68 CYT# potent vascular disrupting 68 including eniluracil ADH 68 Trastuzumab DM1 68 delivers fluocinolone acetonide FA 68 RNAi therapeutic targeting 67 Aganocide 67 Annamycin 67 investigational humanized monoclonal antibody 67 Vitrasert R 67 PEGylated Fab fragment 67 Onalta ™ 67 drug conjugates ADCs 67 kidney urologic 67 DermaVir Patch 67 Presents Preclinical Data 67 Homspera TM 67 pafuramidine maleate 67 PNP inhibitor 67 oncolytic virus therapies 67 Aviptadil 67 liposomal formulation 67 hypoxia activated prodrug 67 cell carcinoma RCC 67 novel peptide 67 cardio metabolic diseases 67 Iluvien ® 67 orally inhaled migraine 67 Solazed TM 67 oral ghrelin agonist 67 intranasal formulation 67 evaluating satraplatin 67 SPL# Gel vaginal microbicide 67 vinca alkaloid 67 investigational monoclonal antibody 67 IMiD 67 PI3K/Akt pathway inhibitor 67 Nanobody 67 receptor tyrosine kinase inhibitor 67 HuMax TAC 67 Initiates Clinical Trial 67 Initiates Enrollment 67 small molecule Hedgehog 67 Zybrestat 67 delivery polymer matrix 67 TELINTRA R 67 IRX 2 67 JAK inhibitor 67 Zalypsis 67 selective immunoproteasome inhibitor 67 M# rationally 67 Tumour Vascular Disrupting Agent 67 antisense inhibitors 67 allosteric modulator NAM 67 SinuNase TM 67 targeting CD# 67 THR beta agonist 67 Safinamide 67 pralatrexate injection folate analogue 67 humanized monoclonal 67 Guanilib 67 tests miRview TM 67 KRYSTEXXA TM pegloticase 66 Archexin 66 Files IND 66 topically applied SEPA 66 DOS# 66 HCV polymerase inhibitors 66 iSONEP TM 66 interferon alpha IFN 66 Pegloticase 66 Anidulafungin 66 product platforms AZX# 66 pan HDAC inhibitor 66 immunotherapeutic agent 66 ALN TTR 66 demonstrated antitumor activity 66 small molecule glucokinase 66 Completes Patient Enrollment 66 peptidic compound 66 MKC# MKC# PP 66 ocular formulation 66 Kosan dependence 66 personalized cellular immunotherapy 66 NS5B polymerase 66 humanized antibody 66 Zolinza 66 trastuzumab Herceptin R 66 Factor VIIa 66 XL# anticancer compounds 66 mitogen activated ERK kinase 66 cetuximab Erbitux R 66 Temsirolimus 66 MAGE A3 ASCI 66 Panzem R NCD 66 candidates Azedra TM 66 signal transduction inhibitor 66 Avila Therapeutics 66 multi kinase inhibitor 66 Aganocide ® 66 myelofibrosis polycythemia vera 66 progressive metastatic prostate 66 PANVAC VF 66 immunotherapeutic vaccine 66 M2 subunit 66 motexafin gadolinium Injection 66 Alvine Pharmaceuticals 66 histone deacetylase HDAC inhibitor 66 candidate TNFerade biologic 66 agonistic human 66 refractory chronic lymphocytic 66 telomerase therapeutic 66 metaglidasen 66 MyVax R 66 PORxin TM 66 recombinant subunit vaccine 66 ALTROPANE R 66 accumulate preferentially 66 Nanobody R 66 ENMD # 66 Phase 2b Clinical Trial 66 FOLOTYN ® 66 polysaccharide polymer 66 Ostabolin C TM 66 Interferon beta 66 non porcine pancreatic 66 HCV protease inhibitor 65 Preclinical Study 65 Bucindolol 65 anti CD3 monoclonal 65 novel VDA molecule 65 reslizumab 65 OvaRex R 65 Civacir 65 Perflubutane Polymer Microspheres 65 formerly LymphoStat B 65 Ridaforolimus 65 Romidepsin 65 Pruvel TM 65 nucleoside analog 65 MT#/MEDI-# 65 engineered proteases 65 cyclophilin inhibitors 65 selective angiogenic kinase inhibitor 65 apricitabine ATC 65 DCVax R 65 IgG1 monoclonal antibody 65 Epratuzumab 65 humanized therapeutic 65 TRO# 65 psoriasis rheumatoid arthritis 65 RhuDex TM 65 anti botulism antibody 65 Imatinib mesylate 65 gefitinib Iressa 65 TLR7 agonist 65 Maribavir 65 humanised monoclonal antibody 65 Phase #b/#a clinical 65 small molecule defensin 65 ABL inhibitor 65 protein tyrosine phosphatase 1B 65 lead molecular radiotherapeutic 65 NS5b 65 siRNA therapeutic 65 BiovaxID TM 65 lexidronam injection 65 gastrin analogue TT 65 PTK# 65 Delafloxacin 65 Arimoclomol 65 essential thrombocythemia ET 65 pertuzumab 65 JAK2 inhibitor 65 targeted immunotherapies 65 dextromethorphan quinidine 65 agent bevasiranib 65 selective kinase inhibitor 65 Receives Orphan Drug Designation 65 IAP inhibitor 65 Initiates Dosing 65 oral nucleoside analogue 65 ONCONASE R 65 hypereosinophilic syndrome 65 CYT# vascular disrupting 65 compound perifosine 65 AMEX KAL 65 kinase inhibition 65 TOCOSOL 65 Panzem NCD 65 XOMA 3AB biodefense 65 cancer immunotherapies 65 Bazedoxifene 65 Atripla combines 65 Micromet BiTE 65 PEGylated interferon 65 delta gamma agonist 65 vapreotide acetate 65 BENLYSTA TM 65 investigational integrase inhibitor 65 platform HDL Mimetic 65 Pancreate 65 Initiates Phase III 65 DPX Survivac 65 R Saizen R 65 Cyclosporin 65 Zenapax 65 selective orally bioavailable 65 PDE# inhibitors 65 IMiDs ® 65 selective androgen receptor modulator 65 ZEVALIN ® 65 OHR/AVR# 65 5 fluorouracil leucovorin 65 hyaluronidase enzyme 65 Omacetaxine 65 HDL Mimetic Peptide 65 IMiDs R 65 BRAF inhibitor 65 Meets Primary Endpoint 65 Maxy G# 65 EGS# 65 vascular disrupting agents 65 oral Janus kinase 65 radezolid 65 Solzira ™ 65 investigational pan BCR 65 RNAi Therapeutic 65 Cannabinor 65 mda 7 65 Vidaza ® 64 rxRNA 64 XL# XL# 64 Fc fusion protein 64 defensin mimetic antibiotic 64 Fludara ® 64 systemic RNAi 64 small molecule agonists 64 BiTE R 64 Evoltra ® 64 injectable investigational 64 GW# [003] 64 Unit Dose Budesonide 64 theranostic 64 ATL# [001] 64 Ostarine ™ 64 Deforolimus 64 semi synthetic lipoglycopeptide 64 Syndax Pharmaceuticals Inc. 64 iSONEP ™ 64 NV1FGF 64 therapeutic monoclonal antibodies 64 dimebon latrepirdine 64 ChronVac C R 64 erlotinib Tarceva ® 64 Muraglitazar 64 modified glutathione analog 64 infectious diseases autoimmune diseases 64 Tesetaxel 64 antibody MAb 64 methylnaltrexone bromide 64 acetonide FA 64 5 FU leucovorin 64 generation purine nucleoside 64 drug GAP #B# 64 HTS assay 64 anti CD3 64 delivered RNAi therapeutic 64 Presents Preclinical 64 Novel Oral 64 ARRY # 64 ZFP Therapeutics 64 Trofex 64 TLR9 agonist 64 CEQ# 64 TBC# 64 PKC# 64 allosteric modulator 64 volociximab 64 Cloretazine ® 64 lintuzumab SGN 64 isoform selective 64 chimeric monoclonal antibody 64 lipid nanoparticle 64 investigational antibiotic 64 Fodosine 64 acyclovir Lauriad R 64 humanized anti 64 oral JAK#/JAK# inhibitor 64 hereditary emphysema 64 R sorafenib tablets 64 PDX pralatrexate 64 Neulasta R 64 VEGFR2 inhibitor 64 OMP #M# 64 Carfilzomib 64 Elotuzumab 64 humanized monoclonal antibody 64 RANK Ligand inhibitor 64 Vidaza R 64 Pathway Inhibitor 64 Begins Dosing 64 ProtAffin 64 alvespimycin 64 MT# MEDI 64 PDE# 64 TLR9 agonists 64 Tezampanel 64 Factor Receptor 64 Imprime PGG ® 64 ribonucleotide reductase clinically validated 64 phase IIb clinical 64 Achieves Primary Endpoint 64 Epeius Biotechnologies Corporation 64 novel immunotherapeutic 64 monoclonal antibody MAb 64 ARIKACE ™ 64 TLK# 64 Granted Orphan Drug 64 DepoVax ™ 64 Receives Orphan Drug 64 Inc. OTCBB LPTN 64 Zenvia ™ 64 selective modulator 64 Xanafide 64 Nanobody ® 64 MTP inhibitor 64 selective estrogen receptor modulator 64 epigenetic therapies 64 vascular disrupting agent 64 Initiate Clinical Trial 64 Pyridorin 64 DiLA2 64 Cloretazine 64 PEG irinotecan 64 neuronal nicotinic receptor NNR 64 polyglutamate 64 Grb 2 64 novel synthetic peptide 64 Receptos 64 apoptosis inducers 64 XmAb 64 Lpathomab 64 tiapamil 64 Belimumab 64 Intermezzo ® zolpidem tartrate 64 Stapled Peptide 64 Hedgehog Pathway Inhibitor 64 XmAb ® 64 systemic RNAi therapeutic 64 personalized immunotherapy 64 Janus kinase 64 Augment TM 64 SUTENT ® 64 mGluR5 negative 64 taxane derivative 64 MSCRAMM ® 64 proprietary HuCNS SC 64 Cardium Therapeutics TM 64 ATRA IV 64 Albugon 64 fosbretabulin 64 preclinically 64 candidate epratuzumab 64 SAR# [002] 64 gemcitabine Gemzar ® 64 UPLYSO 64 TRIOLEX HE# APOPTONE HE# 64 MVA BN R 64 KNS # 64 Vascugel 64 PDE4 inhibitor 64 evaluating picoplatin 64 monoclonal antibody therapeutics 64 AKT inhibitor 64 Kinase Inhibitor 64 BCG refractory carcinoma 64 aurora kinase 64 RhuDex ® 64 compound INCB# 64 CCR9 antagonist 64 SPRYCEL ® 64 Initiate Phase 64 CMV vaccine 64 TBC M4 64 oral beclomethasone dipropionate 64 candidate REP# 63 T#I [002] 63 autologous cellular immunotherapy 63 KL4 Surfactant 63 sunitinib Sutent ® 63 Drug Candidate 63 oral proteasome inhibitor 63 Receives Approvable Letter 63 advanced metastatic renal 63 immunologic diseases 63 Exelixis compounds 63 radiation sensitizer 63 XP# XP# 63 sapropterin dihydrochloride 63 Azacitidine 63 Zemiva TM 63 ASG 5ME 63 NS#/#A protease 63 bevacizumab Avastin ® 63 vosaroxin 63 Sudhir Agrawal D.Phil 63 monoclonal antibody mAb 63 Clolar ® 63 Adnectin 63 Azedra TM 63 HuLuc# 63 anticoagulant reversing agent 63 Locked Nucleic Acid LNA 63 RTP #i 63 overactive bladder AA# 63 OMP #R# 63 Cylene 63 elotuzumab 63 Micromet proprietary BiTE 63 Aplidin 63 MCSP respectively 63 trastuzumab DM1 T DM1 63 immunotoxin 63 huC# DM4 63 therapeutic peptide 63 small molecule tyrosine 63 investigational HCV polymerase 63 histone deacetylase HDAC 63 Empatic ™ 63 Injectable Suspension 63 Pimavanserin 63 bucindolol hydrochloride 63 Vertex hepatitis C 63 HCV polymerase 63 Auxilium transmucosal film 63 ATL# [002] 63 peptidomimetic 63 Genentech Rituxan 63 Initiates Phase 2b 63 pan histone deacetylase 63 histone deacetylase 63 BZL# 63 valtorcitabine 63 NEUGENE R 63 Oracea TM 63 developing Bicifadine serotonin 63 novel orally administered 63 plasmid DNA pDNA 63 class anticancer quinolone 63 Thiovir 63 Liprotamase 63 investigational pharmacologically unique 63 commercializing anti infective 63 IV Busulfex 63 antisense drug 63 HGS# 63 anionic backbone 63 Romiplostim 63 diarrhea predominant irritable 63 hypoxia selective 63 EVIZON TM 63 NASH Huntington 63 Septin9 biomarker 63 Allovectin 7 63 Anavex #-# 63 novel synthetic PEGylated 63 vemurafenib 63 PEGylated 63 lumiliximab 63 HQK 63 Epothilone D 63 PEG SN# 63 Friedreich Ataxia FRDA 63 etanercept Enbrel 63 dasatinib Sprycel 63 MEK inhibitor 63 IL# PE#QQR 63 JAK1 63 vaccine GRNVAC1 63 Isavuconazole 63 Rhucin ® recombinant 63 Affilin ® 63 Intravenous Human 63 introduced NEUGENE 63 cisplatin gemcitabine 63 Kevetrin TM 63 aldehyde dehydrogenase ALDH2 deficiency 63 molecular chaperone regulator 63 multiple sclerosis psoriasis 63 pharmacokinetic PK study 63 TRIOLEX HE# 63 Luteinizing Hormone Releasing Hormone 63 TLR9 agonist IMO 63 candidate AQ4N 63 VitiGam TM 63 Announces Poster Presentations 63 triciribine phosphate monohydrate 63 Solazed ™ 63 Immunotherapeutic 63 Selective Electrochemical Tumor Ablation 63 Therapeutic Competitors Companies 63 multitargeted 63 pharmacogenomic translational research 63 PrevOnco 63 evaluating tivozanib 63 maturation inhibitor 63 small molecule activators 63 Monoclonal antibody 63 human IgG1 monoclonal 63 mertansine 63 peptide peptide mimetic 63 Systemic Delivery 63 FOLFOX6 chemotherapy regimen 63 mGluR2 positive 63 GVAX R 63 GSK# [002] 63 Bezielle 63 Soliris TM eculizumab 63 anti CD3 antibody 63 romidepsin novel 63 fusion enhancers 63 long acting muscarinic 63 cilengitide 63 oral JAK1 63 lorvotuzumab mertansine 63 geldanamycin 63 Tyrima 63 investigational hepatitis C 63 INSPIRE Trial Phase III 63 preclinical efficacy 63 Adenoviral 63 gets USFDA nod 63 anti angiogenic agent 63 treat male hypogonadism 63 relapsed leukemia 63 adecatumumab MT# 63 Elvitegravir 63 highly selective inhibitor 63 tolevamer 63 antiangiogenesis therapies 63 biobetter 63 Uvidem 63 systemic anaplastic large 63 novel RNAi therapeutics 63 AS# amonafide L malate 63 Amgen Neulasta R 63 IgG1 antibody 63 targeted nucleotide prodrug 63 Pafuramidine 63 docetaxel Taxotere ® 63 Phase Ib clinical trials 63 Zarnestra 63 biomarker identification 63 RNA antagonists 63 CCR5 mAb 63 inhaled liposomal ciprofloxacin 63 ASONEP 63 FDA Accepts 63 antiproliferative effects 63 epothilones 63 Receives Milestone Payment 63 allogeneic cell 63 Aurora Kinase 63 5 HT4 63 Interferon alpha 63 Aztreonam 63 small molecule thrombopoietin 63 Pharma Merck Serono 63 histone deacetylase HDAC inhibitors 63 peripherally acting 63 Myolimus 63 www.nanoviricides.com 63 PLK1 SNALP 63 metastatic colorectal 63 A3 adenosine receptor 63 multicenter Phase II 63 toenail onychomycosis 63 endothelin receptor 63 Generx TM 63 ALV# 63 OncoVEX 63 theranostics 63 otelixizumab 63 OTCQB CTIX 63 orally bioavailable 63 antibody MT# 63 Serostim ® 63 EVIZON ™ 63 novel topoisomerase 63 NeuroSTAT ® 63 Initiates Clinical 63 CTAP# Capsules 63 Fenretinide 63 blood serum biomarkers 63 humanized monoclonal antibodies 63 experimental immunotherapeutics antivirals AmpligeGI mucosa resulting 63 Teriflunomide 63 ZFP Therapeutic 63 delipidation 63 Akt inhibitor 63 class mGluR5 inhibitor 63 oxidative stress inducer 63 thrombin component 63 novel orally bioavailable 63 Generx ™ 63 RhuDex R 63 Cerebril TM 63 cMET 63 predictive biomarkers 63 fibrosis IPF 63 TRX1 63 evaluating T DM1 62 commercializing oxidized glutathione 62 3 registrational trial 62 Albuferon albinterferon alfa 2b 62 CD# monoclonal antibody 62 Posiphen TM 62 targeting PCSK9 62 torsemide ER 62 Ceflatonin 62 Talabostat 62 immune modulator 62 interferon gamma 1b 62 XmAb TM 62 docetaxel Taxotere R 62 candidate ridaforolimus 62 Nasdaq ONXX 62 5 HT2A serotonin 62 Dapagliflozin 62 oxaliplatin Eloxatin 62 AEG# 62 Successfully Completes Phase 62 IAP inhibitors 62 Vidofludimus 62 Darinaparsin 62 immunotherapeutics 62 vaccines oncolytic virus 62 histone deacetylase inhibitor 62 bioactive lipids 62 Bioral ® 62 novel oral anticoagulant 62 Apoptone HE# 62 Ecallantide 62 erlotinib Tarceva R 62 Crixivan 62 immunotherapeutic 62 ATPace TM 62 Panzem 62 hormone LHRH antagonist 62 Onco TCS 62 HuMax CD#b 62 vinorelbine tartrate 62 Vidaza azacitidine 62 anti infective treatments 62 Aliskiren 62 Vitro Activity 62 systemically administered 62 factor TNF receptor 62 OSI Tarceva 62 SynCon TM DNA 62 exon skipping 62 vidofludimus 62 initiated Phase 1b 62 Zorbtive TM 62 Troxatyl 62 Neuvenge 62 Submits IND 62 nilotinib Tasigna ® 62 OTCBB PWRM.OB 62 OncoVAX ® 62 platforms GVAX 62 Hsp# Inhibitor 62 TransVax tm 62 Glufosfamide 62 Onalta 62 Phase 2b Trial 62 Endotis 62 TACI Ig 62 topically delivered 62 novel emulsion formulation 62 novel L DOS# 62 CDK cyclin dependent 62 Vicriviroc 62 Bellicum 62 beta 1a 62 Juvaris BioTherapeutics 62 Receives Fast Track 62 tkRNAi 62 sorafenib Nexavar 62 HDL Selective Delipidation 62 developing Zerenex ferric 62 bortezomib Velcade R 62 CCR5 antagonist 62 DermaVir 62 Telatinib 62 nephropathic cystinosis 62 Anti VEGF 62 Novosom 62 TAFA# 62 First Patient Dosed 62 chemosensitizer 62 denileukin diftitox 62 potently inhibit 62 initiated Phase Ib 62 intranasal insulin product 62 EndoTAGTM 1 62 Phase IIb clinical trials 62 selective S#P# receptor agonist 62 AtuRNAi 62 Spiegelmers R 62 p# inhibitor 62 immunological diseases 62 alkylating agent 62 Tarvacin TM 62 CBLC# 62 Cathepsin S 62 cetuximab Erbitux ® 62 pipeline ImmunoGen collaborators 62 Chemokine Therapeutics 62 TRACON Pharmaceuticals 62 anti fibrotic 62 Liposomal 62 angiogenesis inhibitor 62 Campath alemtuzumab 62 paclitaxel poliglumex 62 commercialize deforolimus ARIAD 62 COLAZAL R 62 receptor inhibiting monoclonal 62 4SC AG ISIN DE# 62 ELACYT 62 Piperacillin 62 Gleevec imatinib mesylate 62 5 HT3 antagonist 62 HGS ETR1 mapatumumab 62 fludarabine phosphate 62 cyclin dependent kinase inhibitor 62 Bafetinib 62 Campath ® 62 oncolytic 62 Spiegelmer 62 staphylococcal vaccine 62 forodesine hydrochloride 62 Factor Xa inhibitor 62 Crofelemer budesonide foam 62 TKM ApoB 62 MGN# 62 VentiRx Pharmaceuticals 62 PSN# [002] 62 Progressive Multifocal Leukoencephalopathy 62 HCV NS5B polymerase 62 Aptamer 62 HDAC Inhibitor 62 CCX# 62 glucokinase activator 62 DNA methyltransferase inhibitors 62 RAS MAPK pathway 62 candidate CRLX# 62 Pertuzumab 62 Aeolus Pharmaceuticals Announces 62 Provectus Pharmaceuticals specializes 62 Daclizumab 62 epothilone 62 rALLy clinical trial 62 Virulizin ® 62 ELADUR ™ 62 synthetic retinoid 62 Veronate R 62 cathepsin K inhibitor 62 LHRH antagonists 62 Fx #A 62 Pralatrexate 62 molecularly targeted 62 Valortim TM 62 Nanobodies 62 non nucleoside HCV 62 thiazolides 62 compound AEZS 62 next generation URAT1 62 PHX# 62 romazarit 62 Mipomersen 62 dihydrochloride Tablets 62 AdVac ® 62 prophylactic vaccine 62 Curaxin CBLC# 62 MEK inhibitors 62 Nasdaq VNDA 62 pathophysiological effects 62 Adenosine A2A 62 sirtuin inhibitor program 62 protein kinase inhibitor 62 bevacizumab Avastin R 62 Investigational Compound 62 Silodosin 62 Ixabepilone 62 ZK EPO 62 entinostat 62 Announces Tentative Approval 62 Oxytrex TM 62 Civacir TM Hepatitis C 62 Ovitrelle R Serostim 62 polymerase inhibitor 62 octreotide implant 62 candidate AP# 62 torezolid 62 Ceflatonin R 62 Files Investigational 62 PI3K inhibitor 62 deforolimus 62 Tykerb lapatinib 62 R MSCRAMM 62 Ribavirin causes 62 Nasdaq IDIX biopharmaceutical 62 dexpramipexole 62 Inc. AMEX YMI 62 CINQUIL 62 investigational antiplatelet agent 62 Locked Nucleic Acid 62 MyVax ® 62 trial evaluating PRX# 62 tubulin inhibitor 62 lenalidomide Revlimid 62 sodium thiosulfate STS 62 antagomirs 62 recombinant polyclonal antibody 62 TRANSDUR ® 62 antiangiogenic agent 62 leading oral taxane 62 TNF Tumor Necrosis Factor 62 Aurora kinase inhibitor 62 stable nucleic acid 62 Opterone R 62 Alocrest 62 FUSILEV enhances 62 rNAPc2 62 Actimmune ® 62 Combination REOLYSIN R 62 FOLFOX chemotherapy 62 seliciclib CYC# 62 candidate XP# 62 Submits Biologics License Application 62 GMX# 62 Mycophenolate Mofetil 62 PDE4 modulators 62 IMC #B 62 signal transduction inhibitors 62 EGFr humanized monoclonal antibody 62 Presents Positive 62 inhibit metastasis 62 HyACT 62 candidates Azedra 62 Pruvel 62 PEGylated anti 62 HepeX B 62 oral dual endothelin 62 inhaled formulation 62 receptor monoclonal antibody 62 BiTE 62 Anticalin R 62 inflammatory autoimmune diseases 62 GRNOPC1 contains 62 irinotecan doxorubicin oxaliplatin paclitaxel 62 ALK inhibitor 62 Lenocta 62 imatinib resistance 62 Inc. Nasdaq ALNY 62 BHT DNA 62 mTOR inhibitor 62 mTOR mammalian target 62 RNA antagonist 62 non constipating irritable 62 ospemifene 62 antibody fragment 62 TKB# 62 Modrenal R 62 Myelofibrosis 62 CB2 receptor selective 62 Curaxin 62 SuperAntibody 62 IMiDs ® compound 62 Rigel R# 62 Vaccine Adjuvant 62 synthetic peptide containing 62 CD8 + cytotoxic 62 CD# CEA 62 commercializing therapeutic 62 Intarcia 62 CD# antibody [001] 62 oral dihydropyrimidine dehydrogenase DPD 62 commercialize CorMedix drug 62 XmAb ™ 62 adrenergic regulation 62 novel antibody therapeutics 62 treat secondary hyperparathyroidism 62 TNFerade ™ 62 microtubule inhibitor 62 busulfan 62 DGAT 62 pentostatin 62 selective A2A adenosine receptor 62 S1P antibody 62 Nitazoxanide 61 anthracycline derivative 61 histamine dihydrochloride 61 Reports Preclinical Data 61 Multimeric 61 alkylating 61 immatics 61 poly ADP ribose polymerase 61 mimetics 61 Recombinant Human 61 Diabetic Macular Edema DME 61 phase IIb III 61 Therapeutic Vaccine 61 Submits NDA 61 Neo Kidney Augment 61 Cardiotoxicity 61 itraconazole Sporanox 61 HCD# [002] 61 Xeloda ® 61 oral antiviral 61 highly selective endothelin 61 unique alkylating agent 61 siRNA binds 61 biomodulator 61 proprietary polysaccharide 61 microsomal triglyceride transfer 61 biased ligand 61 HepeX B TM 61 oral anti arrhythmic 61 HGS ETR2 61 multiple myeloma MM 61 markets HP Acthar 61 Myelodysplastic Syndrome MDS 61 Metastatic Melanoma 61 receptor modulators 61 AQUA ® 61 anticancer compound 61 Investigational Oral 61 proven DuraSite ® 61 R#/MEM # 61 CB2 selective receptor agonist 61 pneumocystis pneumonia PCP 61 Nasdaq HALO biopharmaceutical 61 FUSILEV ® 61 P#X# antagonist 61 orally administered pharmacological chaperones 61 mild vasodilator 61 Nasdaq MNKD focused 61 rusalatide acetate